Dry Powder Inhaler Market: North America to Remain Most Lucrative Market for Dry Powder Inhaler: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2026)
- REP-GB-5150
- 2018-02-01
- Category: Healthcare, Pharmaceuticals and Medical devices
- 170 Pages
- Format:
Managed care initiatives along with an aging population demographics is propelling growth of the home health care, and fuelling adoption of self-administered drug therapies. Inhaled medicine is therefore increasingly being discerned as patient-friendly. The inhaled therapy in general, and dry powder inhalers in particular are deemed to be well-positioned for capitalizing on these trends, and evolving as major drivers for future development of the pharmaceutical sector, and commercialization of therapeutic drugs related to respiratory disorders.
Single-use Dry Powder Inhalers gaining Immense Traction owing to their Convenience and Easy Handling
There is a growing prevalence of chronic obstructive pulmonary disorders and asthma across the globe, particularly in developing nations, on the back of growing pollution levels and nicotine consumption. As these nations are cost-sensitive when it comes to expensive therapies regarding various respiratory diseases, demand for low-cost devices is surging across developing countries. In some places with no health insurance facilities, patients tend to share multi-use devices as the complete system become unaffordable for them. Single-use devices are therefore witnessing increased demand as they have the potential to overcome the aforementioned challenges and offer a hygienic & clean device. A major trend being witnessed in the market is the desire for convenience and easy handling of respiratory devices. Multiple dry powder inhalers are being purchased by patients with respiratory diseases as supplementary devices for different places such as cars, job sites, and homes. With single-use dry powder inhalers, patients are enabled to carry exact dose of inhalations required in blister packs, which in turn facilitates handling and convenience.
Some essential performance characteristics of the dry powder inhalers are related to performances at varying airflows, fine particle fraction content, and dose delivery. These characteristics vary in terms of powder formulations, thereby creating the requirement for fine tuning of devices or powder formulations or both combined in order to attain optimal performance. This requirement is relatively higher in the micro-dosing dry powder inhalers. This is further expected to pave opportunities for dry powder inhaler manufacturers based on innovations and advancements.
According to a report recently published by Future Market Insights, the global dry powder inhaler market is projected to register an average expansion through the forecast period, 2017 to 2026, in terms of volume. Worldwide sales of dry powder inhales will exceed 400,000 Mn units by 2026-end.
North America to Remain Largest Market for Dry Powder Inhaler
Presence of a robust healthcare infrastructure coupled with the technologically-advanced practice, mounting number of patients with respiratory disorders, stringent guidelines by regulatory bodies regarding medical devices associated with respiratory disorder therapeutics and relatively higher healthcare spending by the government are key factors that have made North America be the most lucrative market for dry powder inhalers. Sales of dry powder inhalers in North America will exceed 160,000 Mn units by 2026-end.
Chronic obstructive pulmonary disease will continue to be the fast-expanding application of dry powder inhalers. However, dry powder inhaler sales for application in asthma will remain relatively larger than those in chronic obstructive pulmonary disease.
Key Research Findings from FMI’s Report
-
Multi-dose dry powder inhaler will continue to be dominant among products in the market
-
Hospital pharmacies will remain the fastest expanding distribution channel for dry powder inhalers
Competition Tracking
Leading players in the global market for dry powder inhalers are concentrating on developing new generation products. These market players are investing in R&D activities apropos to novel device architectures, powder formulations, and particle engineering. Development of enhanced particle properties, and efficient inhaler designs are expected to remain major strategies among the market participants. The report profiles key market participants, which include Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation, and Vectura Group Plc.
Commonly referred to as metered dose inhalers, dry powder inhalers are used as alternative devices to aerosol-based inhalers and aid in providing medication to lungs. Dry powder inhalers are highly sought-after among patients with respiratory disorders such as COPD, emphysema, bronchitis and asthma, although these devices also have potential use in diabetes mellitus therapeutics. Mounting number of people suffering from diabetes mellitus and respiratory disorders are therefore expected to remain leading revenue contributors to the global dry powder inhaler market.
Future Market Insights (FMI) has recently compiled an insightful report, titled “Global Dry Powder Inhaler Market: Global Industry Analysis (2012-2016) & Opportunity Assessment (2017-2026)”. The report delivers forecasts on the global dry powder inhaler market, and examines the market in detail, providing important dynamics affecting the market expansion. Along with the provision of information on latest market trends, restraining factors, and augmenting factors impacting growth of the market, analysis on the data regarding multiple market parameters has been included in the report.
Report Structure
The report’s initiates with a chapter titled “executive summary”, which issues a summation of global dry powder inhaler market coupled with the information on imperative market numbers such as the historical CAGR (2012-2016) and the forecast CAGR (2017-2026). These numbers rendered are associated with the market segments incorporated in the report. Trailing the executive summary is a chapter titled “overview” that incorporates the definition of “dry powder inhaler”, which succeeds an incisive market introduction. The overview chapter clearly describes the wide scope of global dry powder inhaler market. Some chapters in the report offer information on the pricing analysis coupled with the cost structure regarding the global dry powder inhaler market.
Market Taxonomy
Proceeding further, the report offers forecasts on the global market for dry powder inhaler based on a segmentation analysis. Branching the global market for dry powder inhaler into four key segments viz. application, product type, distribution channel, and region, the report delivers associated market numbers in terms of the market share comparison, Y-o-Y growth comparison, and revenue comparison. The global dry powder inhaler market has been geographically characterized by the report into Latin America, Asia-Pacific excluding Japan (APEJ), North America, Europe, Middle East & Africa (MEA), and Japan.
|
Region |
Product Type |
Distribution Channel |
Application |
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Competition Landscape
A scrupulous analysis regarding the global dry powder inhaler market’s competition landscape has been issued in the concluding chapter of this report, incorporating information on prominent industries that significantly contribute to the market expansion. Occupancy of these market participants is tracked with the aid of an intensity map. Profiling key market participants rigorously, this chapter offers insights based on SWOT analysis, key developments, key financials, company overview, and product overview.
Research Methodology
A robust research methodology, proven & tested, has been employed by TMR’s analysts to develop the report on global dry powder inhaler market. The research methodology used has helped analysts in offering accurate insights related to the global dry powder inhaler market. It depends entirely upon the secondary and primary researches, for gaining important information associated with the market. The information compiled has then been validated by the analysts several times for ensuring the report’s authenticity, and for making it a reliable & authoritative source of reference for readers of the report.
Dry Powder Inhaler Market Reports - Table of Contents
1. Global Economic Outlook
2. Global Dry Powder Inhaler Market - Executive Summary
3. Global Dry Powder Inhaler Market Overview
3.1. Introduction
3.1.1. Global Dry Powder Inhaler Market Taxonomy
3.1.2. Global Dry Powder Inhaler Market Definition
3.2. Global Dry Powder Inhaler Market Size ('000 Units) and Forecast, 2012-2026
3.2.1. Global Dry Powder Inhaler Market Y-o-Y Growth
3.3. Global Dry Powder Inhaler Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. PESTL Analysis
3.8. Product Life Cycle Analysis
3.8. Epidemiology
3.9. Product Evolution
3.10. FDA Approved Products
3.11. List of Distributors
3.12. Key Participants Market Presence (Intensity Map) By Region
4. Global Dry Powder Inhaler Market Supply Demand Analysis
4.1. Number of Manufacturers by Region
4.2. Production Volume by Key Players
4.3. Importer Concentration by Region
4.4. Key Participants Market Presence (Intensity Map) By Region
4.5. North America Production, Consumption, Export, Import and Net Trade Outlook
4.6. Latin America Production, Consumption, Export, Import and Net Trade Outlook
4.7. Europe Production, Consumption, Export, Import and Net Trade Outlook
4.8. Japan Production, Consumption, Export, Import and Net Trade Outlook
4.9. APEJ Production, Consumption, Export, Import and Net Trade Outlook
4.10. MEA Production, Consumption, Export, Import and Net Trade Outlook
5. Pricing Point Analysis
5.1. Price Point Assessment by Region
5.2. Price Point Assessment by Product Type
5.3. Price Forecast till 2026
5.4. Factors Influencing Pricing
5.5. Value Chain Pricing Mark-ups
6. Global Dry Powder Inhaler Market Analysis and Forecast 2012-2026
6.1. Global Dry Powder Inhaler Market Size and Forecast By Product Type, 2012-2026
6.1.1. Single Dose Dry Powder Inhaler Market Size and Forecast, 2012-2026
6.1.1.1. Volume ('000 Unit) Comparison, By Region
6.1.1.2. Market Share Comparison, By Region
6.1.1.3. Y-o-Y growth Comparison, By Region
6.1.2. Multi Dose Dry Powder Inhaler Market Size and Forecast, 2012-2026
6.1.2.1. Volume ('000 Unit) Comparison, By Region
6.1.2.2. Market Share Comparison, By Region
6.1.2.3. Y-o-Y growth Comparison, By Region
6.2. Global Dry Powder Inhaler Market Size and Forecast By Distribution Channel, 2012-2026
6.2.1. Hospitals Pharmacies Market Size and Forecast, 2012-2026
6.2.1.1. Volume ('000 Unit) Comparison, By Region
6.2.1.2. Market Share Comparison, By Region
6.2.1.3. Y-o-Y growth Comparison, By Region
6.2.2. Retail Pharmacies Market Size and Forecast, 2012-2026
6.2.2.1. Volume ('000 Unit) Comparison, By Region
6.2.2.2. Market Share Comparison, By Region
6.2.2.3. Y-o-Y growth Comparison, By Region
6.2.3. Drug Stores Market Size and Forecast, 2012-2026
6.2.3.1. Volume ('000 Unit) Comparison, By Region
6.2.3.2. Market Share Comparison, By Region
6.2.3.3. Y-o-Y growth Comparison, By Region
6.2.4. Online Pharmacies Market Size and Forecast, 2012-2026
6.2.4.1. Volume ('000 Unit) Comparison, By Region
6.2.4.2. Market Share Comparison, By Region
6.2.4.3. Y-o-Y growth Comparison, By Region
6.3. Global Dry Powder Inhaler Market Size and Forecast By Application, 2012-2026
6.3.1. Asthma Market Size and Forecast, 2012-2026
6.3.1.1. Volume ('000 Unit) Comparison, By Region
6.3.1.2. Market Share Comparison, By Region
6.3.1.3. Y-o-Y growth Comparison, By Region
6.3.2. Chronic Obstructive Pulmonary Disease Market Size and Forecast, 2012-2026
6.3.2.1. Volume ('000 Unit) Comparison, By Region
6.3.2.2. Market Share Comparison, By Region
6.3.2.3. Y-o-Y growth Comparison, By Region
6.3.3. Pulmonary Arterial Hypertension Market Size and Forecast, 2012-2026
6.3.3.1. Volume ('000 Unit) Comparison, By Region
6.3.3.2. Market Share Comparison, By Region
6.3.3.3. Y-o-Y growth Comparison, By Region
6.3.4. Others Market Size and Forecast, 2012-2026
6.3.4.1. Volume ('000 Unit) Comparison, By Region
6.3.4.2. Market Share Comparison, By Region
6.3.4.3. Y-o-Y growth Comparison, By Region
7. North America Dry Powder Inhaler Market Size and Forecast, 2012-2026
7.1. North America Outlook
7.2. North America Parent Market Outlook
7.3. North America Target Market Outlook
7.4. Volume ('000 Unit) Comparison, By Country
7.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
7.5. Volume ('000 Unit) Comparison, By Product Type
7.6. Volume ('000 Unit) Comparison, By Distribution Channel
7.7. Volume ('000 Unit) Comparison, By Application
8. Latin America Dry Powder Inhaler Market Size and Forecast, 2012-2026
8.1. Latin America Outlook
8.2. Latin America Parent Market Outlook
8.3. Latin America Target Market Outlook
8.4. Volume ('000 Unit) Comparison, By Country
8.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
8.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
8.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
8.5. Volume ('000 Unit) Comparison, By Product Type
8.6. Volume ('000 Unit) Comparison, By Distribution Channel
8.7. Volume ('000 Unit) Comparison, By Application
9. Europe Dry Powder Inhaler Market Size and Forecast, 2012-2026
9.1. Europe Outlook
9.2. Europe Parent Market Outlook
9.3. Europe Target Market Outlook
9.4. Volume ('000 Unit) Comparison, By Country
9.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. U.K. Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Spain Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. France Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest Of Europe Market Size and Forecast (US$ Mn), 2012-2026
9.5. Volume ('000 Unit) Comparison, By Product Type
9.6. Volume ('000 Unit) Comparison, By Distribution Channel
9.7. Volume ('000 Unit) Comparison, By Application
10. Japan Dry Powder Inhaler Market Size and Forecast, 2012-2026
10.1. Japan Outlook
10.2. Japan Parent Market Outlook
10.3. Japan Target Market Outlook
10.4. Volume ('000 Unit) Comparison, By Country
10.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
10.5. Volume ('000 Unit) Comparison, By Product Type
10.6. Volume ('000 Unit) Comparison, By Distribution Channel
10.7. Volume ('000 Unit) Comparison, By Application
11. APEJ Dry Powder Inhaler Market Size and Forecast, 2012-2026
11.1. APEJ Outlook
11.2. APEJ Parent Market Outlook
11.3. APEJ Target Market Outlook
11.4. Volume ('000 Unit) Comparison, By Country
11.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
11.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
11.4.3. Malaysia Market Size and Forecast (US$ Mn), 2012-2026
11.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
11.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
11.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
11.5. Volume ('000 Unit) Comparison, By Product Type
11.6. Volume ('000 Unit) Comparison, By Distribution Channel
11.7. Volume ('000 Unit) Comparison, By Application
12. MEA Dry Powder Inhaler Market Size and Forecast, 2012-2026
12.1. MEA Outlook
12.2. MEA Parent Market Outlook
12.3. MEA Target Market Outlook
12.4. Volume ('000 Unit) Comparison, By Country
12.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
12.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
12.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
12.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
12.5. Volume ('000 Unit) Comparison, By Product Type
12.6. Volume ('000 Unit) Comparison, By Distribution Channel
12.7. Volume ('000 Unit) Comparison, By Application
13. Global Dry Powder Inhaler Market Company Share, Competition Landscape and Company Profiles
13.1. Competition Dashboard
13.2. Competition Benchmarks
13.3. Profitability and Gross Margin Analysis By Competition
13.4. Competition Developments
13.5. Company Profiles
13.5.1. AstraZeneca Plc
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
13.5.2. 3M Company
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
13.5.3. GlaxoSmithKline Plc
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
13.5.4. Novartis AG
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
13.5.5. Cipla Ltd.
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
13.5.6. Teva Pharmaceutical Industries Limited
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
13.5.7. Boehringer Ingelheim GmbH
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
13.5.8. Chiesi Farmaceutici S.p.A.
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
13.5.9. ELPEN Pharmaceutical Co, Inc.
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
13.5.10. Vectura Group Plc
-
Overview
-
Offering Portfolio
-
Production Footprint
-
Sales Footprint
-
Channel Footprint
-
Strategy Outlook
-
Sales Strategy
-
Channel Strategy
-
Marketing Strategy
-
14. Research Methodology
15. Secondary and Primary Sources
16. Assumptions and Acronyms
17. Disclaimer
Dry Powder Inhaler Market Reports - List of Tables
TABLE 1 Global Dry Powder Inhaler Market Volume ('000 Units), 2012-2017
TABLE 2 Global Dry Powder Inhaler Market Volume ('000 Units), 2018-2026
TABLE 3 Global Dry Powder Inhaler Market Volume ('000 Units) and Y-o-Y, 2017-2026
TABLE 4 Global Single Dose Dry Powder Inhaler Segment Volume ('000 Units), By Region 2012-2017
TABLE 5 Global Single Dose Dry Powder Inhaler Segment Volume ('000 Units), By Region 2018-2026
TABLE 6 Global Single Dose Dry Powder Inhaler Segment Market Share, By Region 2012-2017
TABLE 7 Global Single Dose Dry Powder Inhaler Segment Market Share, By Region 2018-2026
TABLE 8 Global Single Dose Dry Powder Inhaler Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Multi Dose Dry Powder Inhaler Segment Volume ('000 Units), By Region 2012-2017
TABLE 10 Global Multi Dose Dry Powder Inhaler Segment Volume ('000 Units), By Region 2018-2026
TABLE 11 Global Multi Dose Dry Powder Inhaler Segment Market Share, By Region 2012-2017
TABLE 12 Global Multi Dose Dry Powder Inhaler Segment Market Share, By Region 2018-2026
TABLE 13 Global Multi Dose Dry Powder Inhaler Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Hospitals Pharmacies Segment Volume ('000 Units), By Region 2012-2017
TABLE 15 Global Hospitals Pharmacies Segment Volume ('000 Units), By Region 2018-2026
TABLE 16 Global Hospitals Pharmacies Segment Market Share, By Region 2012-2017
TABLE 17 Global Hospitals Pharmacies Segment Market Share, By Region 2018-2026
TABLE 18 Global Hospitals Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Retail Pharmacies Segment Volume ('000 Units), By Region 2012-2017
TABLE 20 Global Retail Pharmacies Segment Volume ('000 Units), By Region 2018-2026
TABLE 21 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 22 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 23 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Drug Stores Segment Volume ('000 Units), By Region 2012-2017
TABLE 25 Global Drug Stores Segment Volume ('000 Units), By Region 2018-2026
TABLE 26 Global Drug Stores Segment Market Share, By Region 2012-2017
TABLE 27 Global Drug Stores Segment Market Share, By Region 2018-2026
TABLE 28 Global Drug Stores Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Online Pharmacies Segment Volume ('000 Units), By Region 2012-2017
TABLE 30 Global Online Pharmacies Segment Volume ('000 Units), By Region 2018-2026
TABLE 31 Global Online Pharmacies Segment Market Share, By Region 2012-2017
TABLE 32 Global Online Pharmacies Segment Market Share, By Region 2018-2026
TABLE 33 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Asthma Segment Volume ('000 Units), By Region 2012-2017
TABLE 35 Global Asthma Segment Volume ('000 Units), By Region 2018-2026
TABLE 36 Global Asthma Segment Market Share, By Region 2012-2017
TABLE 37 Global Asthma Segment Market Share, By Region 2018-2026
TABLE 38 Global Asthma Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Chronic Obstructive Pulmonary Disease Segment Volume ('000 Units), By Region 2012-2017
TABLE 40 Global Chronic Obstructive Pulmonary Disease Segment Volume ('000 Units), By Region 2018-2026
TABLE 41 Global Chronic Obstructive Pulmonary Disease Segment Market Share, By Region 2012-2017
TABLE 42 Global Chronic Obstructive Pulmonary Disease Segment Market Share, By Region 2018-2026
TABLE 43 Global Chronic Obstructive Pulmonary Disease Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Pulmonary Arterial Hypertension Segment Volume ('000 Units), By Region 2012-2017
TABLE 45 Global Pulmonary Arterial Hypertension Segment Volume ('000 Units), By Region 2018-2026
TABLE 46 Global Pulmonary Arterial Hypertension Segment Market Share, By Region 2012-2017
TABLE 47 Global Pulmonary Arterial Hypertension Segment Market Share, By Region 2018-2026
TABLE 48 Global Pulmonary Arterial Hypertension Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Others Segment Volume ('000 Units), By Region 2012-2017
TABLE 50 Global Others Segment Volume ('000 Units), By Region 2018-2026
TABLE 51 Global Others Segment Market Share, By Region 2012-2017
TABLE 52 Global Others Segment Market Share, By Region 2018-2026
TABLE 53 Global Others Segment Y-o-Y, By Region 2017-2026
TABLE 54 North America Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
TABLE 55 North America Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
TABLE 56 North America Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
TABLE 57 North America Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
TABLE 58 North America Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
TABLE 59 North America Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
TABLE 60 North America Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
TABLE 61 North America Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
TABLE 62 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
TABLE 63 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
TABLE 64 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
TABLE 65 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
TABLE 66 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
TABLE 67 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
TABLE 68 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
TABLE 69 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
TABLE 70 Europe Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
TABLE 71 Europe Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
TABLE 72 Europe Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
TABLE 73 Europe Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
TABLE 74 Europe Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
TABLE 75 Europe Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
TABLE 76 Europe Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
TABLE 77 Europe Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
TABLE 78 Japan Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
TABLE 79 Japan Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
TABLE 80 Japan Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
TABLE 81 Japan Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
TABLE 82 Japan Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
TABLE 83 Japan Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
TABLE 84 Japan Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
TABLE 85 Japan Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
TABLE 86 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
TABLE 87 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
TABLE 88 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
TABLE 89 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
TABLE 90 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
TABLE 91 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
TABLE 92 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
TABLE 93 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
TABLE 94 MEA Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
TABLE 95 MEA Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
TABLE 96 MEA Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
TABLE 97 MEA Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
TABLE 98 MEA Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
TABLE 99 MEA Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
TABLE 100 MEA Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
TABLE 101 MEA Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
Dry Powder Inhaler Market Reports - List of Figures
FIG. 1 Global Dry Powder Inhaler Market Volume ('000 Units), 2012-2017
FIG. 2 Global Dry Powder Inhaler Market Volume ('000 Units) Forecast, 2018-2026
FIG. 3 Global Dry Powder Inhaler Market Volume ('000 Units) and Y-o-Y, 2017-2026
FIG. 4 Global Single Dose Dry Powder Inhaler Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 5 Global Single Dose Dry Powder Inhaler Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 6 Global Single Dose Dry Powder Inhaler Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Multi Dose Dry Powder Inhaler Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 8 Global Multi Dose Dry Powder Inhaler Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 9 Global Multi Dose Dry Powder Inhaler Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Hospitals Pharmacies Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 11 Global Hospitals Pharmacies Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 12 Global Hospitals Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Retail Pharmacies Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 14 Global Retail Pharmacies Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 15 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Drug Stores Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 17 Global Drug Stores Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 18 Global Drug Stores Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Online Pharmacies Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 20 Global Online Pharmacies Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 21 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Asthma Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 23 Global Asthma Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 24 Global Asthma Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Chronic Obstructive Pulmonary Disease Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 26 Global Chronic Obstructive Pulmonary Disease Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 27 Global Chronic Obstructive Pulmonary Disease Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Pulmonary Arterial Hypertension Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 29 Global Pulmonary Arterial Hypertension Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 30 Global Pulmonary Arterial Hypertension Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Others Segment Market Volume ('000 Units) By Region, 2012-2017
FIG. 32 Global Others Segment Market Volume ('000 Units) By Region, 2018-2026
FIG. 33 Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 North America Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
FIG. 35 North America Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
FIG. 36 North America Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
FIG. 37 North America Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
FIG. 38 North America Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
FIG. 39 North America Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
FIG. 40 North America Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
FIG. 41 North America Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
FIG. 42 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
FIG. 43 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
FIG. 44 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
FIG. 45 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
FIG. 46 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
FIG. 47 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
FIG. 48 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
FIG. 49 Latin America Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
FIG. 50 Europe Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
FIG. 51 Europe Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
FIG. 52 Europe Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
FIG. 53 Europe Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
FIG. 54 Europe Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
FIG. 55 Europe Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
FIG. 56 Europe Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
FIG. 57 Europe Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
FIG. 58 Japan Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
FIG. 59 Japan Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
FIG. 60 Japan Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
FIG. 61 Japan Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
FIG. 62 Japan Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
FIG. 63 Japan Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
FIG. 64 Japan Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
FIG. 65 Japan Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
FIG. 66 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
FIG. 67 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
FIG. 68 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
FIG. 69 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
FIG. 70 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
FIG. 71 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
FIG. 72 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
FIG. 73 APEJ Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026
FIG. 74 MEA Dry Powder Inhaler Market Volume ('000 Units), By Country 2012-2017
FIG. 75 MEA Dry Powder Inhaler Market Volume ('000 Units), By Country 2018-2026
FIG. 76 MEA Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2012-2017
FIG. 77 MEA Dry Powder Inhaler Market Volume ('000 Units), By Product Type 2018-2026
FIG. 78 MEA Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2012-2017
FIG. 79 MEA Dry Powder Inhaler Market Volume ('000 Units), By Distribution Channel 2018-2026
FIG. 80 MEA Dry Powder Inhaler Market Volume ('000 Units), By Application 2012-2017
FIG. 81 MEA Dry Powder Inhaler Market Volume ('000 Units), By Application 2018-2026